Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95.

Autor: Maretbayeva SM; Partners In Health, Almaty, Kazakhstan., Rakisheva AS; JSC 'National Medical University' named after Asfendiyarov, Kazakhstan., Adenov MM; National Scientific Center of Phthisiopulmonology of the Ministry of Health of the Republic of Kazakhstan, Kazakhstan., Yeraliyeva LT; National Scientific Center of Phthisiopulmonology of the Ministry of Health of the Republic of Kazakhstan, Kazakhstan., Algozhin YZ; Partners In Health, Almaty, Kazakhstan., Stambekova AT; Partners In Health, Almaty, Kazakhstan., Berikova EA; National Scientific Center of Phthisiopulmonology of the Ministry of Health of the Republic of Kazakhstan, Kazakhstan., Yedilbayev A; World Health Organization Regional Office for Europe, Kazakhstan., Rich ML; Partners In Health, Boston, USA; Harvard Medical School, Boston, USA., Seung KJ; Partners In Health, Boston, USA; Harvard Medical School, Boston, USA., Issayeva AM; JSC 'National Medical University' named after Asfendiyarov, Kazakhstan. Electronic address: issayeva17@mail.ru.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 Aug; Vol. 121, pp. 105. Date of Electronic Publication: 2022 May 23.

Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia.

Autor: Soedarsono, Soedarsono, Mertaniasih, Ni Made, Kusmiati, Tutik, Permatasari, Ariani, Subay, Susi, Adiono, Suko Hari

Publikováno v: International Journal of Mycobacteriology; Apr-Jun2024, Vol. 13 Issue 2, p140-146, 7p